S-3 – Page 7 – China Stock Advice

NFEC [NF Energy Saving] S-3:

[] [Golenbock Eiseman Assor Bell & Peskoe LLP 437 Madison Avenue New York, New York 10022 May 23, 2014 NF Energy Corporation 3106 Tower C, 390 Qingnian Avenue HePing District, Shenyang, P. R. China 110015 Ladies and Gentlemen: For the purpose of the opinions set forth below, we have also assumed, without independent investigation or verification, that: (d) the Registration Statement] [Consent of Independent Registered Public Accounting Firm The Board of Directors NF Energy Saving Corporation We consent to the incorporation by reference in the Registration Statement of NF Energy Saving Corporation (the “Company”) on Form S-3 of our report dated March 20, 2014 on our audit of the Company’s financial statements as of December 31, 2013 and 2012, and the]

By info| 2016-03-29T02:28:47+00:00 May 23rd, 2014|Categories: Chinese Stocks, NFEC, Webplus ver|Tags: 0001213660, 2014-05-23, 3490, MISCELLANEOUS FABRICATED METAL PRODUCTS, NFEC, S-3|0 Comments

ONP [Orient Paper] S-3: (Original Filing)

[FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ORIENT PAPER, INC. Nevada (State or other jurisdiction of incorporation or organization) 20-4158835 (I.R.S. Employer Identification Number) Science Park, Juli Road Zhenyong Liu (Name, address, including zip code, and telephone number, including area code, of agent for service) Copy to: Jack I. Kantrowitz Approximate date of commencement of proposed sale] [ORIENT PAPER, INC. TO as Trustee INDENTURE Dated as of , 20 * CROSS REFERENCE SHEET Section of the Act Section of Indenture 310(a)(1) and (2) 6.09 310(a)(3) and (4) Inapplicable 310(b) 6.08 and 6.10(a), (b) and (d) 311(a) 6.13 311(b) 6.13 312(a) 4.01 and 4.02(a) 312(b) 4.02(a) and (b) 312(c) 4.02(c) 313(a) 4.04(a) 313(b)(1) Inapplicable 313(b)(2) 4.04(a) 313(c) 4.04(a)] [May 20, 2014 Orient Paper, Inc. Science Park, Juli Road Ladies and Gentlemen: Company Registration Statement Commission Act Shares Common Stock Debt Securities Indenture Units Securities Unit Agreement We have acted as special Nevada counsel to Orient Paper, Inc., a Nevada corporation (the “ In our capacity as such counsel, we are familiar with the proceedings taken and proposed to] [May 20, 2014 Orient Paper, Inc. Science Park, Juli Road, Xushui County, Baoding City Hebei Province, The People’s Republic of China 072550 Ladies and Gentlemen: Based upon the foregoing, and upon such other investigation as we have deemed necessary and subject to the qualifications set forth below, we are of the opinion that: Very truly yours, DLA Piper LLP (US)] [Consent of Independent Registered Public Accounting Firm Orient Paper, Inc. We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement on Form S-3 of our reports dated March 25, 2014, relating to the consolidated financial statements of Orient Paper, Inc. appearing in the Company’s Annual Report on Form 10-K for the year]

By info| 2016-03-13T21:09:40+00:00 May 20th, 2014|Categories: Chinese Stocks, ONP, SEC Original|Tags: 0001358190, 2014-05-20, 2670, CONVERTED PAPER and PAPERBOARD PRODS (NO CONTAINERS/BOXES), ONP, S-3|0 Comments

ONP [Orient Paper] S-3: FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT

[FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ORIENT PAPER, INC. Nevada (State or other jurisdiction of incorporation or organization) 20-4158835 (I.R.S. Employer Identification Number) Science Park, Juli Road Zhenyong Liu (Name, address, including zip code, and telephone number, including area code, of agent for service) Copy to: Jack I. Kantrowitz Approximate date of commencement of proposed sale] [ORIENT PAPER, INC. TO as Trustee INDENTURE Dated as of , 20 * CROSS REFERENCE SHEET Section of the Act Section of Indenture 310(a)(1) and (2) 6.09 310(a)(3) and (4) Inapplicable 310(b) 6.08 and 6.10(a), (b) and (d) 311(a) 6.13 311(b) 6.13 312(a) 4.01 and 4.02(a) 312(b) 4.02(a) and (b) 312(c) 4.02(c) 313(a) 4.04(a) 313(b)(1) Inapplicable 313(b)(2) 4.04(a) 313(c) 4.04(a)] [May 20, 2014 Orient Paper, Inc. Science Park, Juli Road Ladies and Gentlemen: Company Registration Statement Commission Act Shares Common Stock Debt Securities Indenture Units Securities Unit Agreement We have acted as special Nevada counsel to Orient Paper, Inc., a Nevada corporation (the “ In our capacity as such counsel, we are familiar with the proceedings taken and proposed to] [May 20, 2014 Orient Paper, Inc. Science Park, Juli Road, Xushui County, Baoding City Hebei Province, The People’s Republic of China 072550 Ladies and Gentlemen: Based upon the foregoing, and upon such other investigation as we have deemed necessary and subject to the qualifications set forth below, we are of the opinion that: Very truly yours, DLA Piper LLP (US)] [Consent of Independent Registered Public Accounting Firm Orient Paper, Inc. We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement on Form S-3 of our reports dated March 25, 2014, relating to the consolidated financial statements of Orient Paper, Inc. appearing in the Company’s Annual Report on Form 10-K for the year]

By info| 2016-03-13T21:10:50+00:00 May 20th, 2014|Categories: Chinese Stocks, ONP, Webplus ver|Tags: 0001358190, 2014-05-20, 2670, CONVERTED PAPER and PAPERBOARD PRODS (NO CONTAINERS/BOXES), ONP, S-3|0 Comments

CREG [CHINA RECYCLING ENERGY] S-3: (Original Filing)

[] [Albany Atlanta Brussels Denver Los Angeles Miami New York Thomas Wardell (404) 527-4990 Northern Virginia Orange County Rancho Santa Fe San Diego San Francisco Seoul email address twardell@mckennalong.com March 10, 2014 Board of Directors China Recycling Energy Corporation 12/F, Tower A Chang An International Building No. 88 Nan Guan Zheng Jie Xi’an City, Shaanxi Province, China Re: Resale Registration Statement] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 of China Recycling Energy Corporation of our report dated March 19, 2013 relating to the financial statements which appear in the 2012 Annual Report on Form 10-K. We also consent to the reference to us under the heading]

By info| 2016-03-14T16:57:40+00:00 March 10th, 2014|Categories: Chinese Stocks, CREG, SEC Original|Tags: 0000721693, 2014-03-10, 7389, CREG, S-3, SERVICES-BUSINESS SERVICES, NEC|0 Comments

CREG [CHINA RECYCLING ENERGY] S-3:

[] [Albany Atlanta Brussels Denver Los Angeles Miami New York Thomas Wardell (404) 527-4990 Northern Virginia Orange County Rancho Santa Fe San Diego San Francisco Seoul email address twardell@mckennalong.com March 10, 2014 Board of Directors China Recycling Energy Corporation 12/F, Tower A Chang An International Building No. 88 Nan Guan Zheng Jie Xi’an City, Shaanxi Province, China Re: Resale Registration Statement] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 of China Recycling Energy Corporation of our report dated March 19, 2013 relating to the financial statements which appear in the 2012 Annual Report on Form 10-K. We also consent to the reference to us under the heading]

By info| 2016-03-14T16:58:31+00:00 March 10th, 2014|Categories: Chinese Stocks, CREG, Webplus ver|Tags: 0000721693, 2014-03-10, 7389, CREG, S-3, SERVICES-BUSINESS SERVICES, NEC|0 Comments

BSPM [Biostar Pharmaceuticals,] S-3: (Original Filing)

[FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Biostar Pharmaceuticals, Inc. Maryland (State or other jurisdiction of incorporation or organization) 2834 (Primary Standard Industrial Code Number) 20-8747899 (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province The People’s Republic of China, 712046 011-86-29-33686638 (Address, including zip code, and telephone number, Ronghua Wang Chief Executive Officer] [BIOSTAR PHARMACEUTICALS, INC. TO AS TRUSTEE INDENTURE DATED AS OF , 20 SENIOR DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.1 DEFINITIONS 1 SECTION 1.2 COMPLIANCE CERTIFICATES AND OPINIONS] [BIOSTAR PHARMACEUTICALS, INC. TO AS TRUSTEE INDENTURE DATED AS OF , 20 SUBORDINATED DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.1 DEFINITIONS 1 SECTION 1.2 COMPLIANCE CERTIFICATES AND OPINIONS 9] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 dated December 18, 2013 of Biostar Pharmaceuticals, Inc. of our report dated April 11, 2013 relating to the consolidated financial statements, which appears in the Annual Report on Form 10-K] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Inc. Certified Public Accountants Hong Kong December 19, 2013 EX-23.2 5 ex23-2.htm EX-23.2]

By info| 2016-03-03T10:30:45+00:00 December 19th, 2013|Categories: BSPM, Chinese Stocks, SEC Original|Tags: 0001418133, 2013-12-19, 2834, BSPM, PHARMACEUTICAL PREPARATIONS, S-3|0 Comments

BSPM [Biostar Pharmaceuticals,] S-3: FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT

[FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Biostar Pharmaceuticals, Inc. Maryland (State or other jurisdiction of incorporation or organization) 2834 (Primary Standard Industrial Code Number) 20-8747899 (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province The People’s Republic of China, 712046 011-86-29-33686638 (Address, including zip code, and telephone number, Ronghua Wang Chief Executive Officer] [BIOSTAR PHARMACEUTICALS, INC. TO AS TRUSTEE INDENTURE DATED AS OF , 20 SENIOR DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.1 DEFINITIONS 1 SECTION 1.2 COMPLIANCE CERTIFICATES AND OPINIONS] [BIOSTAR PHARMACEUTICALS, INC. TO AS TRUSTEE INDENTURE DATED AS OF , 20 SUBORDINATED DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.1 DEFINITIONS 1 SECTION 1.2 COMPLIANCE CERTIFICATES AND OPINIONS 9] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 dated December 18, 2013 of Biostar Pharmaceuticals, Inc. of our report dated April 11, 2013 relating to the consolidated financial statements, which appears in the Annual Report on Form 10-K] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Inc. Certified Public Accountants Hong Kong December 19, 2013 EX-23.2 5 ex23-2.htm EX-23.2]

By info| 2016-03-03T10:32:16+00:00 December 19th, 2013|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: 0001418133, 2013-12-19, 2834, BSPM, PHARMACEUTICAL PREPARATIONS, S-3|0 Comments

BSPM [Biostar Pharmaceuticals,] S-3: (Original Filing)

[FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Biostar Pharmaceuticals, Maryland (State or other jurisdiction oforporation or organization) 2834 (Primary Standard Industrialde Number) 20-8747899 (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province The Peoples Republic of China, 712046 011-86-29-33686638 (Address,luding zipde, and telephone number,] [BIOSTAR PHARMACEUTICALS, TO TRUSTEE INDENTURETED OF , 20 SENIOR DEBT SECURITIES TABLE OFNTENTS Page ARTICLE1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION1.1 DEFINITIONS 1 SECTION1.2MPLIANCE CERTIFICATES AND OPINIONS 8 SECTION1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 8 SECTION1.4 ACTS OF HOLDERS; RECORDTES] [BIOSTAR PHARMACEUTICALS, TO TRUSTEE INDENTURETED OF , 20 SUBORDINATED DEBT SECURITIES TABLE OFNTENTS Page ARTICLE1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION1.1 DEFINITIONS 1 SECTION1.2MPLIANCE CERTIFICATES AND OPINIONS 9 SECTION 1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 10 SECTION 1.4 ACTS OF HOLDERS; RECORDTES] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Certified Public Accountants Hong Kong December 19, 2013 EX-23.1 ex23-1.htm 4 EX-23.1] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Certified Public Accountants Hong Kong December 19, 2013 EX-23.2 ex23-2.htm 5 EX-23.2]

By info| 2016-02-07T15:00:18+00:00 December 19th, 2013|Categories: BSPM, Chinese Stocks, SEC Original|Tags: 0001418133, 2013-12-19, 2834, BSPM, PHARMACEUTICAL PREPARATIONS, S-3|0 Comments

BSPM [Biostar Pharmaceuticals,] S-3: FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT

[FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Biostar Pharmaceuticals, Maryland (State or other jurisdiction oforporation or organization) 2834 (Primary Standard Industrialde Number) 20-8747899 (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province The Peoples Republic of China, 712046 011-86-29-33686638 (Address,luding zipde, and telephone number,] [BIOSTAR PHARMACEUTICALS, TO TRUSTEE INDENTURETED OF , 20 SENIOR DEBT SECURITIES TABLE OFNTENTS Page ARTICLE1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION1.1 DEFINITIONS 1 SECTION1.2MPLIANCE CERTIFICATES AND OPINIONS 8 SECTION1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 8 SECTION1.4 ACTS OF HOLDERS; RECORDTES] [BIOSTAR PHARMACEUTICALS, TO TRUSTEE INDENTURETED OF , 20 SUBORDINATED DEBT SECURITIES TABLE OFNTENTS Page ARTICLE1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION1.1 DEFINITIONS 1 SECTION1.2MPLIANCE CERTIFICATES AND OPINIONS 9 SECTION 1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 10 SECTION 1.4 ACTS OF HOLDERS; RECORDTES] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Certified Public Accountants Hong Kong December 19, 2013 EX-23.1 ex23-1.htm 4 EX-23.1] [CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM To the Board of Directors of Biostar Pharmaceuticals, Certified Public Accountants Hong Kong December 19, 2013 EX-23.2 ex23-2.htm 5 EX-23.2]

By info| 2016-02-07T15:00:53+00:00 December 19th, 2013|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: 0001418133, 2013-12-19, 2834, BSPM, PHARMACEUTICAL PREPARATIONS, S-3|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] S-3: (Original Filing)

[FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Skystar Bio-Pharmaceutical Company Nevada 2834 33-0901534 (State or other jurisdiction (Primary Standard Industrial (I.R.S. Employer of incorporation or organization) Code Number) Identification Number) 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District Xi’an, Shaanxi Province, P.R. China (8629) 8819-3188 (Address, including zip code, and telephone number, Bing Mei] [SKYSTAR BIO-PHARMACEUTICAL COMPANY TO AS TRUSTEE INDENTURE DATED AS OF , 20 SENIOR DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.1 DEFINITIONS 1 SECTION 1.2 COMPLIANCE CERTIFICATES AND OPINIONS 8 SECTION 1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 8] [SKYSTAR BIO-PHARMACEUTICAL COMPANY TO AS TRUSTEE INDENTURE DATED AS OF , 20 SUBORDINATED DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.1 DEFINITIONS 1 SECTION 1.2 COMPLIANCE CERTIFICATES AND OPINIONS 9 SECTION 1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 10] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 and related Prospectus of our report dated April 1, 2013 relating to the consolidated financial statements, which appears in Skystar Bio-Pharmaceutical Company’s Annual Report on Form 10-K for the year ended December 31, 2012. We also consent to] [Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in this Registration Statement on Form S-3 and related Prospectus of Skystar Bio-Pharmaceutical Company of our report dated March 30, 2012 relating to the December 31, 2011 consolidated financial statements appearing in the Annual Report on Form 10-K of Skystar Bio-Pharmaceutical Company for the year ended]

By info| 2016-03-01T03:51:18+00:00 December 4th, 2013|Categories: Chinese Stocks, SEC Original, SKBI|Tags: 0001076939, 2013-12-04, 2834, PHARMACEUTICAL PREPARATIONS, S-3, SKBI|0 Comments